The amyloid fibrils of the constant domain of immunoglobulin light chain

FEBS Letters

Volumn 584, Issue 15, 2010, Pages 3348-3353

  Yamamoto, Kaori ^a   Yagi, Hisashi ^a   Lee, Young Ho ^a   Kardos, József ^b   Hagihara, Yoshihisa ^c   Naiki, Hironobu ^d   Goto, Yuji ^a  

^a OSAKA UNIVERSITY   (Japan)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

2 Microglobulin; AL amyloidosis; Amyloid fibril; Dialysis related amyloidosis; Immunoglobulin domain

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTICLE; DIALYSIS; ELECTRON MICROSCOPY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMYLOID; CIRCULAR DICHROISM; FLUORESCENCE; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN LIGHT CHAINS; PROTEIN STRUCTURE, TERTIARY; SONICATION; THIAZOLES;

EID: 77955280729     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.06.019     Document Type: Article

References (40)

1. Dobson C.M. Protein folding and misfolding. Nature 2003, 426:884-890.
2. Cohen F.E., Kelly J.W. Therapeutic approaches to protein-misfolding diseases. Nature 2003, 426:905-909.
3. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
4. Yamamoto S., Gejyo F. Historical background and clinical treatment of dialysis-related amyloidosis. Biochim. Biophys. Acta 2005, 1753:4-10.
5. Hurle M.R., Helms L.R., Li L., Chan W., Wetzel R. A role for destabilizing amino acid replacements in light-chain amyloidosis. Proc. Natl. Acad. Sci. USA 1994, 91:5446-5450.
6. Khurana R., Gillespie J.R., Talapatra A., Minert L.J., Ionescu-Zanetti C., Millett I., Fink A.L. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 2001, 40:3525-3535.
7. Takahashi N., Hasegawa K., Yamaguchi I., Okada H., Ueda T., Gejyo F., Naiki H. Establishment of a first-order kinetic model of light chain-associated amyloid fibril extension in vitro. Biochim. Biophys. Acta 2002, 1601:110-120.
8. Bellotti V., Mangione P., Merlini G. Review: immunoglobulin light chain amyloidosis - the archetype of structural and pathogenic variability. J. Struct. Biol. 2000, 130:280-289.
9. Gertz M.A., Lacy M.Q., Lust J.A., Greipp P.R., Witzig T.E., Kyle R.A. Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis. Am. J. Hematol. 1999, 61:115-119.
10. Solomon A., Weiss D.T., Murphy C.L., Hrncic R., Wall J.S., Schell M. Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Proc. Natl. Acad. Sci. USA 1998, 95:9547-9551.
11. Engvig J.P., Olsen K.E., Gislefoss R.E., Sletten K., Wahlstrom O., Westermark P. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand. J. Immunol. 1998, 48:92-98.
12. Feige M.J., Groscurth S., Marcinowski M., Yew Z.T., Truffault V., Paci E., Kessler H., Buchner J. The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity. Proc. Natl. Acad. Sci. USA 2008, 105:13373-13378.
13. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
14. 2-microglobulin. J. Biol. Chem. 2005, 280:32843-32848.
15. Chatani E., Lee Y.H., Yagi H., Yoshimura Y., Naiki H., Goto Y. Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils. Proc. Natl. Acad. Sci. USA 2009, 106:11119-11124.
16. 2-microglobulin. Biochemistry 2007, 46:3286-3293.
17. 2-microglobulin under acidic and neutral pH conditions. Biochemistry 2008, 47:2650-2660.
18. 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 2004, 43:11075-11082.
19. 2-microglobulin-related amyloid fibrils at a neutral pH. J. Am. Soc. Nephrol. 2004, 15:126-133.
20. 2-microglobulin. J. Biol. Chem. 2003, 278:47016-47024.
21. Doering D.S., Matsudaira P. Cysteine scanning mutagenesis at 40 of 76 positions in villin headpiece maps the F-actin binding site and structural features of the domain. Biochemistry 1996, 35:12677-12685.
22. Hagihara Y., Matsuda T., Yumoto N. Cellular quality control screening to identify amino acid pairs for substituting the disulfide bonds in immunoglobulin fold domains. J. Biol. Chem. 2005, 280:24752-24758.
23. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 1967, 6:1948-1954.
24. 2-microglobulin amyloid fibrils at neutral pH. J. Biol. Chem. 2005, 280:12012-12018.
25. 2-microglobulin at neutral pH. J. Mol. Biol. 2008, 376:258-268.
26. Naiki H., Hashimoto N., Suzuki S., Kimura H., Nakakuki K., Gejyo F. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid 1997, 4:223-232.
27. Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411:810-813.
28. Saa P., Castilla J., Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 2006, 281:35245-35252.
29. Hirota N., Mizuno K., Goto Y. Group additive contributions to the alcohol-induced α-helix formation of melittin: implication for the mechanism of the alcohol effects on proteins. J. Mol. Biol. 1998, 275:365-378.
30. 2-microglobulin fragment are induced by fluorine-substituted alcohols. J. Mol. Biol. 2006, 363:279-288.
31. Goto Y., Hamaguchi K. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. J. Biochem. 1979, 86:1433-1441.
32. 2-microglobulin is not essential for the immunoglobulin fold at neutral pH, but is essential for amyloid fibril formation at acidic pH. J. Biochem. (Tokyo) 2002, 131:45-52.
33. 2-microglobulin amyloid fibril growth and stability. Biochemistry 2005, 44:1288-1299.
34. Goto Y., Takahashi N., Fink A.L. Mechanism of acid-induced folding of proteins. Biochemistry 1990, 29:3480-3488.
35. Klement K., Wieligmann K., Meinhardt J., Hortschansky P., Richter W., Fandrich M. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's Aβ(1-40) amyloid fibrils. J. Mol. Biol. 2007, 373:1321-1333.
36. Biancalana M., Makabe K., Koide A., Koide S. Molecular mechanism of thioflavin-T binding to the surface of β-rich peptide self-assemblies. J. Mol. Biol. 2009, 385:1052-1063.
37. Wu C., Biancalana M., Koide S., Shea J.E. Binding modes of thioflavin-T to the single-layer β-sheet of the peptide self-assembly mimics. J. Mol. Biol. 2009, 394:627-633.
38. Biancalana M., Koide S. Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 2010, 1804:1405-1412.
39. Feige M.J., Hagn F., Esser J., Kessler H., Buchner J. Influence of the internal disulfide bridge on the folding pathway of the CL antibody domain. J. Mol. Biol. 2007, 365:1232-1244.
40. Goldschmidt L., Teng P.K., Riek R., Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. USA 2010, 107:3487-3492.